Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer (original) (raw)
Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma
Ana Markovic
Expert Review of Anticancer Therapy, 2012
View PDFchevron_right
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
Andre Eckardt
British Journal of Cancer, 2007
View PDFchevron_right
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
Mahmut Ozsahin
Radiation oncology (London, England), 2006
View PDFchevron_right
Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions
Jan Vermorken, Marc Hamoir, Carlos Suárez
Cancer Treatment Reviews, 2014
View PDFchevron_right
Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck
Walid Shaib
Journal of Oncology, 2012
View PDFchevron_right
Review Article Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck
Walid Shaib
2016
View PDFchevron_right
Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer
andrew kobets
Expert Review of Anticancer Therapy, 2006
View PDFchevron_right
Epidermal growth factor receptor pathway as therapeutic development in head and neck cancers: present and future
Cesar Perez
Oncology Reviews, 2009
View PDFchevron_right
Biologic therapy in head and neck cancer: a road with hurdles
Pol Specenier
ISRN oncology, 2012
View PDFchevron_right
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
Ajay Matta
Head & Neck Oncology, 2009
View PDFchevron_right
Current aspects of targeted therapy in head and neck tumors
Gunnar Wichmann
European Archives of Oto-Rhino-Laryngology, 2008
View PDFchevron_right
Molecular targeted therapies in head and neck cancer - An update of recent developements
Holger Sudhoff
Head & Neck Oncology, 2010
View PDFchevron_right
Apoptosis and growth inhibition of head and neck tumor cell line induced by epidermal growth factor receptor tyrosine kinase inhibitor
khalil ahmed
Oral Oncology, 1999
View PDFchevron_right
Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers
Carol Box
Frontiers in Bioscience, 2013
View PDFchevron_right
Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
Yasumasa Kato
Journal of oncology, 2012
View PDFchevron_right
Targeted therapy in head and neck cancer
Stefano Pelucchi
Cancer, 2008
View PDFchevron_right
Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck
Peter Sacks
Cancer research, 1989
View PDFchevron_right
Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Activity in Human Cell Lines Established from Squamous Carcinomas of the Head and Neck1
Peter Sacks
Cancer Research, 1989
View PDFchevron_right
Molecularly targeted therapies in head and neck cancers
Michał Szczyrek
Otolaryngologia Polska, 2012
View PDFchevron_right
Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck
susanne rogers
The Journal of Pathology, 2009
View PDFchevron_right
Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
Denis Soulières
Journal of Clinical Oncology, 2004
View PDFchevron_right
Biological agents in head and neck cancer
Paolo Bossi
Annals of Oncology, 2006
View PDFchevron_right
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy
Fernando Paragliola
Therapeutic Advances in Medical Oncology
View PDFchevron_right
Targeted therapies in head and neck cancer
Jan Vermorken, Pol Specenier
Targeted Oncology, 2007
View PDFchevron_right
Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
Kenneth Shroyer
British journal of cancer, 2013
View PDFchevron_right
Breakthrough targeted therapeutic approaches to squamous cell carcinoma of the head and neck
Alberto Mangano
Future Oncology, 2015
View PDFchevron_right
Cell Signalings and the Communications in Head and Neck Cancer
Yasumasa Kato
Head and Neck Cancer, 2012
View PDFchevron_right
Clinical development of molecular targeted therapy in head and neck squamous cell carcinoma
Camille Moreau-Bachelard
JNCI Cancer Spectrum
View PDFchevron_right
Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance
Jan Vermorken, Pol Specenier
The Oncologist, 2013
View PDFchevron_right
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting
Michael Graner
Clinical cancer …, 2006
View PDFchevron_right